Toux < Toxicité < Toxicologie

Facettes :

List of bibliographic references indexed by Toxicité

Number of relevant bibliographic references: 219.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
002593 (2008)	Anthony H. V. Schapira [Royaume-Uni]	The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease
002C78 (2007)	Martin Niethammer [États-Unis] ; Blair Ford [États-Unis]	Permanent lithium‐induced cerebellar toxicity: Three cases and review of literature
003420 (2006)	Katie Kompoliti [États-Unis] ; Christopher G. Goetz [États-Unis] ; Mary Morrissey [États-Unis] ; Sue Leurgans [États-Unis]	Gilles de la Tourette syndrome: Patient's knowledge and concern of adverse effects
003742 (2005)	Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis]	Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations
003796 (2005)	Katherine Widnell [États-Unis]	Pathophysiology of motor fluctuations in Parkinson's disease
003811 (2005)	Cheryl Waters [États-Unis]	Other pharmacological treatments for motor complications and dyskinesias
003844 (2005)	Joseph Jankovic [États-Unis]	Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
003E05 (2004)	Brian K. Lassinger [États-Unis] ; Carolyn Kwak [États-Unis] ; Roy L. Walford [États-Unis] ; Joseph Jankovic [États-Unis]	Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: A possible complication of chronic hypoxia and carbon monoxide toxicity?
003F15 (2003)	John M. Walshe [Royaume-Uni]	The story of penicillamine: A difficult birth
003F69 (2003)	Padraig O'Suilleabhain [États-Unis] ; Cole Giller [États-Unis]	Rapidly progressive parkinsonism in a self‐reported user of Ecstasy and other drugs
003F72 (2003)	Charles H. Adler [États-Unis] ; John N. Caviness [États-Unis] ; Joseph G. Hentz [États-Unis] ; Marlene Lind [États-Unis] ; Judy Tiede [États-Unis]	Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease
004016 (2003)	Ali Samii [États-Unis] ; Debra D. Dahlen [États-Unis] ; Alexander M. Spence [États-Unis] ; Nicole C. Maronian [États-Unis] ; Eric E. Kraus [États-Unis] ; Vanda A. Lennon [États-Unis]	Paraneoplastic movement disorder in a patient with non‐Hodgkin's lymphoma and CRMP‐5 autoantibody
004020 (2003)	Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel [Allemagne] ; Jörg Kazenwadel [Suisse] ; Thomas C. Wetter [Allemagne] ; Wolfgang Oertel [Allemagne] ; Roland Selzer [Allemagne] ; Ralf Kohnen [Allemagne]	One‐year treatment with standard and sustained‐release levodopa: Appropriate long‐term treatment of restless legs syndrome?
004085 (2003)	Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada]	Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease
004139 (2003)	Eduardo Tolosa [Espagne] ; Miguel Coelho [Espagne] ; Marisol Gallardo [Espagne]	DAT imaging in drug‐induced and psychogenic parkinsonism
004155 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire [Canada] ; Abdallah Hadj Tahar [Canada] ; Paul J. Bédard [Canada]	Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeys
004159 (2003)	Cathy Chuang [États-Unis] ; Anne Constantino [États-Unis] ; Casilda Balmaceda [États-Unis] ; David Eidelberg [États-Unis] ; Steven J. Frucht [États-Unis]	Chemotherapy‐induced parkinsonism responsive to levodopa: An underrecognized entity
004160 (2003)	Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]	Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa‐induced motor complications
004173 (2003)	Noël L. W. Keijsers [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Stan C. A. M. Gielen [Pays-Bas]	Automatic assessment of levodopa‐induced dyskinesias in daily life by neural networks
004176 (2003)	Isabelle Benatru [France] ; Stéphane Thobois [France] ; Nathalie Andre-Obadia [France] ; Pierre-Marie Gonnaud [France] ; Yara Beaugendre [France] ; Colette Berger [France] ; Michel Gonce [Belgique] ; Emmanuel Broussolle [France]	Atypical propriospinal myoclonus with possible relationship to α interferon therapy
004180 (2003)	Georg Ebersbach [Allemagne]	An artist's view of drug‐induced hallucinosis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Toxicité" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Toxicité" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Toxicité
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024